Targeting myelin lipid metabolism as a potential therapeutic strategy in a 
model of CMT1A neuropathy

Fledrich, Robert; Abdelaal, Tamer A. M.; Rasch, Lennart; Bansal, V.; Schütza, Vlad; Brügger, B.; Lüchtenborg, C.; Prukop, Thomas; Stenzel, Jan; Rahman, R.U.; Hermes, Doris; Ewers, David; Möbius, Wiebke; Ruhwedel, Torben; Katona, I.; Weis, J.; Klein, D.; Martini, R.; Brück, W.; Müller, W.C.; Bonn, S.; Bechmann, I.; Nave, Klaus-Armin; Stassart, Ruth M.; Sereda, Michael Werner

doi:10.1038/s41467-018-05420-0

Item

ITEM ACTIONSEXPORT

Add to Basket

Please note that a newer version of this item is available:
https://pure.mpg.de/pubman/item/item_2630229_5

DetailsSummary

Released

Journal Article

Targeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathy

MPS-Authors

/persons/resource/persons182152

Fledrich, Robert
Molecular and translational neurology, Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons182057

Abdelaal, Tamer A. M.
Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons182363

Rasch, Lennart
Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons224786

Schütza, Vlad
Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons182356

Prukop, Thomas
Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons224788

Stenzel, Jan
Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons224792

Hermes, Doris
Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons224794

Ewers, David
Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons182306

Möbius, Wiebke
Electron microscopy, Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons182382

Ruhwedel, Torben
Electron microscopy, Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons182320

Nave, Klaus-Armin
Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons182427

Stassart, Ruth M.
Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons182406

Sereda, Michael Werner
Molecular and translational neurology, Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

Fledrich_18.pdf
(Publisher version), 5MB

Supplementary Material (public)

There is no public supplementary material available

Citation

Fledrich, R., Abdelaal, T. A. M., Rasch, L., Bansal, V., Schütza, V., Brügger, B., et al. (2018). Targeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathy. Nature Communications, 9: 3025. doi:10.1038/s41467-018-05420-0.

Cite as: https://hdl.handle.net/21.11116/0000-0001-E40B-2

Abstract

There is no abstract available